Open AccessPreliminary 12-Month Safety and Efficacy Outcomes for the Treatment of Cervical Radiculopathy and Myelopathy with the Stalif-C Integrated Interbody Fusion Device
Author(s) -
Barrett S. Boody,
Jad Khalil Khalil,
Betsy H. Grunch,
Michael J. Musacchio,
Amir Vokshoor,
R. F. Wilson,
Rick C. Sasso
Publication year - 2021
Language(s) - English
DOI - 10.47363/jsar/2021(2)128
Subject(s) - medicine , myelopathy , anterior cervical discectomy and fusion , surgery , cage , complication , cervical vertebrae , cervical radiculopathy , cervical spine , spinal cord , mathematics , combinatorics , psychiatry
Anterior cervical discectomy and fusion (ACDF) has been widely utilized as the workhorse approach for the surgical treatment of cervical degenerative pathology. Minimal high-level evidence data exists on the efficacy and safety of integrated cage-screw implants. A prospective, non-randomized clinical study utilizing STALIF C-Ti® integrated cage-screw implants was performed in 145 patients. 12-month outcome scores demonstrated significant improvements in all patient reported outcome scores collected (p<0.05 for all), including NDI, VAS neck, VAS left arm, and VAS right arm. Patients receiving STALIF C-Ti integrated cage-screw implants demonstrated significant improvements in clinical outcome scores with minimal overall complication rate